The HSP90 pharmacological inhibitor, 17-AAG, enhances breast-bone metastasis in a nude mouse model and stimulates in vitro and in vivo osteoclast formation
John T. Price(The University of Melbourne), Erik W. Thompson(Translational Research Institute), D. E. Myers, Matthew T. Gillespie(Hudson Institute of Medical Research), Mark Waltham(Center for Information Technology), Susan Docherty, Asako Nakamura(Ibaraki University), Jill K. Moore, Natalie A. Sims(The University of Melbourne), Kelly Waldeck, J Quinn(The University of Melbourne)
Cancer Treatment Reviews
January 1, 2005
Cited by 1
Related Papers
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536